By Jonathan Kimmelman, associate professor at McGill University and director of its Biomedical Ethics Unit, and Alex John London (Carnegie Mellon) 

There is a lot of money behind providing cancer care, and cancer treatment centers spend an estimated $173 million on advertising each year. One of the ways they compete for patients is by offering a menu of clinical trial options and suggesting that participating in such trials gives patients an edge on their care.

Classified as: bioethics, Clinical trials, mcgill medicine
Category:
Published on: 25 Apr 2018

Prescriptions for dangerous alternatives to OxyContin are soaring, showing that a crackdown on the popular painkiller has failed to curb Canada’s opioid crisis.

Classified as: medicine, McGill University, ethics, McGill, Nicholas King, epidemic, Crisis, Expert, social studies, bioethics, opioid
Category:
Published on: 12 Apr 2016
Back to top